Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TLV/ILX stock hub

TLV/ILX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/ILXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

607.7M

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/ILX

In the news

Latest news · TLV/ILX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E10.9

P25 n/aP50 n/aP75 n/a

ROE8.3

P25 n/aP50 n/aP75 n/a

ROIC8.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/ILX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

ILS

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	181
Employees Change	3%
Employees Change Percent	1.69
Enterprise value	ILA 419.2M
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Medical Devices
Isin	IL0010807530
Last refreshed	2026-05-10
Market cap	ILA 607.7M
Price	ILA 5,412
Price currency	ILA
Rev Per Employee	5,142,723.76x
Sector	Healthcare
Sic	5047
Symbol	tlv/ILX
Website	https://www.ilexmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.14%
EV Earnings	7.55x
EV/EBIT	9.28x
EV/EBITDA	4.52x
EV/FCF	9.14x
EV/Sales	0.45x
FCF yield	7.55%
P/B ratio	0.89x
P/E ratio	10.94x
P/S ratio	0.65x
PE Ratio10 Y	12.8x
PE Ratio3 Y	14.81x
PE Ratio5 Y	12.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6%
EBITDA Margin	9.58%
FCF margin	4.93%
Gross margin	22.76%
Gross Profit	ILA 211.9M
Gross Profit Growth	-2.05%
Gross Profit Growth Q	5.39%
Gross Profit Growth3 Y	-9.19%
Gross Profit Growth5 Y	-4.8%
Net Income	ILA 55.6M
Net Income Growth	42.52%
Net Income Growth Q	180.21%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	-18.37%
Net Income Growth5 Y	-14.36%
Pretax Margin	7.96%
Profit Margin	5.97%
Profit Per Employee	ILA 306,934
Profitable Years	12
ROA	3.51
Roa5y	8.27
ROCE	7.57
ROE	8.35
Roe5y	16.31
ROIC	8.58
Roic5y	23.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.95%
Cagr15y	7.65%
Cagr1y	-8.35%
Cagr20y	5.95%
Cagr3y	-10.23%
Cagr5y	-10.7%
Div CAGR10	7.14%
Div CAGR3	13.33%
Div CAGR5	-17.88%
EPS Growth	42.52
EPS Growth Q	179.1
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	-18.15
EPS Growth5 Y	-15.08
FCF Growth	-11.53%
FCF Growth3 Y	1.72%
FCF Growth5 Y	-19.78%
OCF Growth	-10.73%
OCF Growth10 Y	4.9%
OCF Growth3 Y	1.47%
OCF Growth5 Y	-16.77%
Revenue Growth	1.14x
Revenue Growth Q	5.92x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	2.54x
Revenue Growth5 Y	-0.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.94
Assets	ILA 992.7M
Cash	ILA 235.1M
Current Assets	ILA 723.7M
Current Liabilities	ILA 255.4M
Debt	ILA 46.6M
Debt EBITDA	ILA 0.45
Debt Equity	ILA 0.07
Debt FCF	ILA 1.02
Equity	ILA 684.7M
Interest Coverage	27.06
Liabilities	ILA 308M
Long Term Assets	ILA 269.1M
Long Term Liabilities	ILA 52.6M
Net Cash	ILA 188.5M
Net Cash By Market Cap	ILA 31.02
Net Cash Growth	1.61%
Net Debt EBITDA	ILA -2.11
Net Debt Equity	ILA -0.28
Net Debt FCF	ILA -4.11
Tangible Book Value	ILA 665.8M
Tangible Book Value Per Share	ILA 59.51
WACC	3.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.83
Inventory Turnover	4.08
Net Working Capital	ILA 246.9M
Quick ratio	1.99
Working Capital	ILA 468.3M
Working Capital Turnover	ILA 2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	62.87%
Dividend Growth Years	0%
Dividend per share	ILA 1.99
Dividend Years	6
Dividend Yield	3.66%
Ex Div Date	2026-04-10
Last Dividend	ILA 1.99
Payout Frequency	Annual
Payout Ratio	24.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	114.93%
1Y total return	-8.35%
200-day SMA	6,226.5
3Y total return	-27.67%
50-day SMA	5,800.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-43.22%
All Time High	17,070
All Time High Change	-68.3%
All Time High Date	2022-02-02
All Time Low	241.3
All Time Low Change	2,142.54%
All Time Low Date	1996-09-02
ATR	217.1
Beta	-0.18
Beta1y	-0.14
Beta2y	-0.04
Ch YTD	-18.81
High	5,441
High52	7,085
High52 Date	2025-11-20
High52ch	-23.61%
Low	5,395
Low52	5,377
Low52 Date	2026-04-17
Low52ch	0.65%
Ma50ch	-6.69%
Price vs 200-day SMA	-13.08%
RSI	39.44
RSI Monthly	37.38
RSI Weekly	65.21
Sharpe ratio	-0.38x
Sortino ratio	-0.29
Total Return	3.66%
Tr YTD	-16.02
Tr15y	202.2%
Tr1m	-6.88%
Tr1w	-2.77%
Tr3m	-8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA 55.8M
Operating Income Growth	-11.1
Operating Income Growth Q	75.59
Operating Income Growth3 Y	-27.49
Operating Income Growth5 Y	-17.56
Operating margin	6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,836,547%
Net Borrowing	-13,684,000
Shares Insiders	62.77%
Shares Institutions	10.49%
Shares Out	11,188,107
Shares Qo Q	-0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 45.9M
Average Volume	6,309.15x
Bv Per Share	61.2
CAPEX	ILA -27M
Ch10y	54.63
Ch15y	78.38
Ch1m	-9.98
Ch1w	-2.77
Ch1y	-11.39
Ch20y	49.92
Ch3m	-11.06
Ch3y	-32.85
Ch5y	-50.35
Ch6m	-19.39
Change	0.32%
Change From Open	0.32
Close	5,395
Days Gap	0
Depreciation Amortization	33,356,000
Dollar Volume	54,774,852
Earnings Date	2026-04-03
EBIT	ILA 55.8M
EBITDA	ILA 89.2M
EPS	ILA 4.97
F Score	6
FCF	ILA 45.9M
FCF EV Yield	10.95x
FCF Per Share	ILA 4.1
Financing CF	-27,327,000
Fiscal Year End	December
Founded	1,990
Goodwill	7,005,000
Graham Number	82.68998
Graham Upside	-98.47
Income Tax	ILA 18.6M
Investing CF	-46,649,000
Is Primary Listing	1
Last Earnings Date	2025-11-25
Last Report Date	2025-12-31
Last Split Date	2000-08-21
Last Split Type	Forward
Lynch Fair Value	ILA 24.83
Lynch Upside	-99.54
Ma150	6,273.3
Ma150ch	-13.73%
Ma20	5,598
Ma20ch	-3.32%
Net CF	-1,659,000
Open	5,395
P FCF Ratio	13.24
P OCF Ratio	8.34
Payment Date	2026-04-20
Position In Range	36.96
Ppne	147,223,000
Price Date	2026-05-08
Price EBITDA	ILA 6.82
Ptbv Ratio	0.91
Relative Volume	1.6x
Revenue	930,833,000x
Tax By Revenue	2x
Tax Rate	25.06%
Tr20y	217.73%
Tr6m	-16.62%
Volume	10,121
Z Score	3.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TLV/ILX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.7%

$1.99 annual per share

Payout ratio

+24.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-17.9%

0 consecutive years of growth

Total shareholder yield

+3.7%

Next ex-dividend date: 2026-04-10

Performance

TLV/ILX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/ILX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.5%

Share of float held by funds and institutions

Insider ownership

+62.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TLV/ILX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.4

Neutral momentum band

Price vs 200-day MA

-13.1%

50/200-day relationship not available

Beta (5Y)

-0.18

Less volatile than the market

Sharpe ratio

-0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/ILX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/ILX stock rating?

tlv/ILX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/ILX analysis?

The full report lives at /stocks/tlv/ILX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/ILX?

The latest report frames tlv/ILX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/ILX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.